| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2014 | US8883077 Disinfecting, nonbleaching N-halamine for use with contact lens |
| 11/11/2014 | US8883010 Polymer composition with phytochemical and dialysis membrane formed from the polymer composition |
| 11/11/2014 | US8882743 Apparatus and method for application of a pharmaceutical to the tympanic membrane for photodynamic laser myringotomy |
| 11/11/2014 | US8882691 Nail correcting device and medical set for nail correction |
| 11/11/2014 | US8882075 Furnace mount |
| 11/11/2014 | US8881894 Multiple-compartment applicator |
| 11/06/2014 | US20140330252 Biomatrix structural containment and fixation systems and methods of use thereof |
| 11/06/2014 | US20140330246 Intrauterine fetal growth restriction - The biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements |
| 11/06/2014 | US20140330223 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 11/06/2014 | US20140330195 Compositions and methods for controlling neuronal excitation |
| 11/06/2014 | US20140330192 Dressing for application to a wound or burn |
| 11/06/2014 | US20140330022 Collateral blood circulation development promoter |
| 11/06/2014 | US20140330021 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof |
| 11/06/2014 | US20140330007 2,4-pyrimidinediamine compounds and their uses |
| 11/06/2014 | US20140330005 Polysaccharide therapeutic conjugates |
| 11/06/2014 | US20140329914 Amphiphilic Peptides for Thoracic Air Leakage Occlusion |
| 11/06/2014 | US20140329912 Contraceptive compositions and methods of contraception |
| 11/06/2014 | US20140329911 Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker |
| 11/06/2014 | US20140329908 Method For The Treatment of Dravet Syndrome |
| 11/06/2014 | US20140329907 Catecholamine derivatives for obesity and neurological disorders |
| 11/06/2014 | US20140329906 Thermogelling anaesthetic compositions |
| 11/06/2014 | US20140329905 Histone deacetylase 10-inhibitor co-treatment in cancer |
| 11/06/2014 | US20140329904 Increasing the bioavailability of hydroxycinnamic acids |
| 11/06/2014 | US20140329903 Treatment of neurodegenerative diseases |
| 11/06/2014 | US20140329902 Lysine delivery systems for blood coagulation |
| 11/06/2014 | US20140329901 Compounds for treatment of cell proliferative diseases |
| 11/06/2014 | US20140329897 Composition for treating influenza a (h1n1) virus and a preparation method therefor |
| 11/06/2014 | US20140329896 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
| 11/06/2014 | US20140329894 Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease |
| 11/06/2014 | US20140329893 Therapeutic compositions |
| 11/06/2014 | US20140329892 Administration of a bis(thiohydrazide amide) compound for treating cancers |
| 11/06/2014 | US20140329885 Lipids, lipid complexes and use thereof |
| 11/06/2014 | US20140329884 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
| 11/06/2014 | US20140329879 Diagnosis and treatment of taxane-resistant cancers |
| 11/06/2014 | US20140329876 Pyrazoline derivatives and their use as selective androgen receptor modulators |
| 11/06/2014 | US20140329875 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers |
| 11/06/2014 | US20140329874 Alpha adrenergic agonists for the treatment of tissue trauma |
| 11/06/2014 | US20140329872 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| 11/06/2014 | US20140329869 Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| 11/06/2014 | US20140329868 Methods for treating hypertension |
| 11/06/2014 | US20140329867 Inhibitors of notch signalling pathway and use thereof in treatment of cancers |
| 11/06/2014 | US20140329861 Neosaxitoxin Combination Formulations for Prolonged Local Anesthesia |
| 11/06/2014 | US20140329859 Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability |
| 11/06/2014 | US20140329856 Method of treating pain |
| 11/06/2014 | US20140329853 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors |
| 11/06/2014 | US20140329849 Hdac inhibitors to treat charcot-marie-tooth disease |
| 11/06/2014 | US20140329847 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment |
| 11/06/2014 | US20140329846 Morphinan Compounds |
| 11/06/2014 | US20140329845 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 11/06/2014 | US20140329844 Method of restoring the incretin effect |
| 11/06/2014 | US20140329843 High dose buprenorphine compositions and use as analgesic |
| 11/06/2014 | US20140329841 Neosaxitoxin Combination Formulations for Prolonged Local Anesthesia |
| 11/06/2014 | US20140329839 New Crystalline Form of Pemirolast |
| 11/06/2014 | US20140329835 Dosage form for insertion into the mouth |
| 11/06/2014 | US20140329833 Lysine demethylase inhibitors for inflammatory diseases or conditions |
| 11/06/2014 | US20140329832 Metabolic degradation inhibitors for anti-hyperproliferative agents |
| 11/06/2014 | US20140329827 Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| 11/06/2014 | US20140329825 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 11/06/2014 | US20140329824 Therapeutic compositions containing macitentan |
| 11/06/2014 | US20140329814 Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases |
| 11/06/2014 | US20140329811 Methods of Modulating Cell Proliferation and Cyst Formation in Polycystic Kidney and Liver Diseases |
| 11/06/2014 | US20140329810 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 11/06/2014 | US20140329805 Dual small molecule inhibitors of cancer and angiogenesis |
| 11/06/2014 | US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors |
| 11/06/2014 | US20140329797 Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors |
| 11/06/2014 | US20140329793 Pharmaceutical compositions and uses thereof |
| 11/06/2014 | US20140329791 Compounds and related methods for treatment of neurodegenerative diseases |
| 11/06/2014 | US20140329790 USE OF 5 alpha-ANDROSTANE-3 beta,5,6 beta-TRIOL IN PREPARATION OF NEUROPROTECTIVE DRUGS |
| 11/06/2014 | US20140329789 Methods for Inhibiting the Development of Huntington's Disease |
| 11/06/2014 | US20140329788 Testosterone gel and method of use |
| 11/06/2014 | US20140329786 Combination treatment of cancer |
| 11/06/2014 | US20140329785 Conveniently Injectable or Implantable Sustained-Release Antioxidant Formulations for Therapies of Ocular Maladies or Cancer |
| 11/06/2014 | US20140329784 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| 11/06/2014 | US20140329783 Transdermal hormone replacement therapies |
| 11/06/2014 | US20140329782 Combined therapeutic agent |
| 11/06/2014 | US20140329781 Methods for treating cardiovascular disorder |
| 11/06/2014 | US20140329780 Inhibitor of colonisation of mucosa |
| 11/06/2014 | US20140329779 Clear solid sticks with solubilized pharmaceutical agents |
| 11/06/2014 | US20140329777 Methods to treat infections |
| 11/06/2014 | US20140329776 Mitochondria-Targeted Antioxidants for Treatment of Age-Related Brain Disorders |
| 11/06/2014 | US20140329775 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference |
| 11/06/2014 | US20140329774 Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof |
| 11/06/2014 | US20140329773 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease |
| 11/06/2014 | US20140329770 Compositions Comprising Phytoestrogens Receptor Beta Agonists and Dietary Fibers for Chemopreventive Treatment of Sporadic Adenomatous Polyposis |
| 11/06/2014 | US20140329767 Compositions and Methods for Preventing and Treating Diseases and Environmentally Induced Health Disorders |
| 11/06/2014 | US20140329766 Prophylactic Compositions for Management of Microbial Infections in Patients with Brain Injury |
| 11/06/2014 | US20140329761 Prevention and treatment of acute inflammatory conditions |
| 11/06/2014 | US20140329756 Temperature-release catalyst for cross-linking halyuronic acid during injection |
| 11/06/2014 | US20140329755 Combination therapy for the treatment of arrhythmias or heart failure |
| 11/06/2014 | US20140329754 Compositions and methods for treating myelodysplastic syndrome |
| 11/06/2014 | US20140329751 Method for sensitizing cells to cancer therapy |
| 11/06/2014 | US20140329740 Anti-infective hydroxy-phenyl-benzoates and methods of use |
| 11/06/2014 | US20140329738 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 11/06/2014 | US20140329286 Equol concentration increasing agent containing psicose as active ingredient |
| 11/06/2014 | US20140328973 Method of releasing nicotine from chewing gum |
| 11/06/2014 | US20140328956 Use Of Two Botanicals With Complementary Activities For Improvement Of Skin |
| 11/06/2014 | US20140328954 Herbal/organic composition for the management of pain |
| 11/06/2014 | US20140328953 Skin preparation composition for external use having excellent antiseptic ability |
| 11/06/2014 | US20140328951 Composition for Preventing and Treating Vision Deterioration and Age-Related Macular Degeneration through Retinal Repair Using Ginseng/Red Ginseng Extracts and Ginsenoside |
| 11/06/2014 | US20140328948 Buffered compositions for dialysis |